Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Apr 29, 2021 · 10-Q · 29 days after period end · 0001069530-21-000027
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$3.53M | -$1.15M | -$1.36M | -$2.16M |
| EPS Diluted | -$0.09 | -$0.05 | -$0.08 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Apr 29, 2021 · 29 d after period end
